Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Frontiers in Nutrition|October 10, 2025
Integrative natural health solutions for midlife womenVanita Dahia, Will Shannon, Anastasia Suraev, et al.
Advanced Drug Delivery Reviews|July 29, 2008
Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's diseaseAnnette Maczurek, Klaus Hager, Marlene Kenklies, et al.
Journal of Natural Products|July 4, 2024
Triplinones A-H: Anti-Inflammatory Arylalkenyl α,β-Unsaturated-δ-Lactones Isolated from the Leaves of Australian Rainforest Plant Cryptocarya triplinervis (Lauraceae)Paayal Kumar, Matthew Wallis, Xian Zhou, et al.
Fitoterapia|February 4, 2021
Identification of tetragocarbone C and sideroxylin as the most potent anti-inflammatory components of Syncarpia glomuliferaMadhuri Venigalla, Tara Laurine Roberts, Ritesh Raju, et al.
Rejuvenation Research|May 27, 2011
The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinaseMartina Krautwald, Dale Leech, Stacey Horne, et al.
Journal of Immunological Methods|July 23, 2002
Characterization of antibody affinities using an AGE-modified dipeptide spot librarySladjana Dukic-Stefanovic, Dorothee Schicktanz, Amanda Wong, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|February 27, 2013
Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort studySyed Ziaur Rahman, Jim Basilakis, Anton Rahmadi, et al.
Neurobiology of Aging|January 18, 2005
Immunochemical crossreactivity of antibodies specific for "advanced glycation endproducts" with "advanced lipoxidation endproducts"Torsten Richter, Gerald Münch, Hans-Joachim Lüth, et al.
Cerebral Cortex (New York, N.Y. : 1991)|July 9, 2004
Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brainsHans-Joachim Lüth, Vera Ogunlade, Björn Kuhla, et al.
Journal of Alzheimer'S Disease : JAD|April 11, 2016
Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's DiseaseTanya Jayne, Morgan Newman, Giuseppe Verdile, et al.
Pageof 15